U.S - Liquid Biopsy Potential Testing Market & Analysis to 2020

Atlanta,USA, April 19, 2016 (Newswire.com) - Liquid Biopsy technology has huge treatment and diagnostics implications for Oncology in future. Liquid Biopsies fall in non-invasive blood test category. It is a new test to detect people with cancer have tumor DNA in their blood. Liquid Biopsies test improves detection of tumor DNA in blood. Currently United States is its biggest market globally. USA liquid biopsy screening market is set to be a Billion dollar market by 2020. Liquid Biopsies Screening market share will decline year on year from 2015, but it will continue to hold majority market share till 2020. If we analyze liquid biopsy by screening potential market then Colorectal Cancer and Breast Cancer together controls nearly 50% of market share. Liquid Biopsy Breast cancer market is set to reach close to USD 500 Million by 2020.

Renub Research report titled “United States – Liquid Biopsy Potential Testing Market & Volume Analysis to 2020” provides a comprehensive assessment of the fast–evolving, high–growth of Liquid Biopsy Market. This 79 page report with 41 Figures analyses the United States Liquid Biopsy Test Market and Volume by 5 Top Cancer Segment, Recent developments, Major Deals along with the driving factors and challenges for Liquid Biopsy Market.

1.    Executive Summary

2.     United States - Liquid Biopsy Potential Market (2015 – 2020)

2.1   United States - Liquid Biopsy Potential Market

2.2   United States - Liquid Biopsy Screening Potential Market

2.3   United States - Liquid Biopsy Treatment Monitoring Potential Market

3.     United States - Liquid Biopsy Potential Test Volume (2015 – 2020)

3.1   United States - Liquid Biopsy Potential Test Volume

3.2   United States - Liquid Biopsy Potential Screening Test Volume

3.3   United States - Liquid Biopsy Potential Treatment Monitoring Test Volume

4.     United States - Liquid Biopsy Potential Market Share (2015 – 2020)

4.1   United States - Liquid Biopsy Potential Market Share by Method

4.2   United States - Liquid Biopsy Screening Potential Market Share by Cancer Types

4.3   United States - Liquid Biopsy Treatment Monitoring Potential Market Share by Cancer Types

5.     United States - Liquid Biopsy Potential Market & Test Volume by Cancer Types (2015 – 2020)

5.1     United States - Liquid Biopsy Lung Cancer Potential Market & Test Volume

5.1.1   United States - Liquid Biopsy Lung Cancer Potential Market

5.1.2   United States - Liquid Biopsy Lung Cancer Potential Test Volume

5.2      United States - Liquid Biopsy Breast Cancer Potential Market & Test Volume

5.3      United States - Liquid Biopsy Colorectal Cancer Potential Market & Test Volume

5.4     United States - Liquid Biopsy Prostate Cancer Potential Market & Test Volume

5.5     United States - Liquid Biopsy Liver Cancer Potential Market & Test Volume

6.      United States - Liquid Biopsy Screening Potential Market & Test Volume by Cancer Types (2015 – 2020)

7.    United States - Liquid Biopsy Treatment Monitoring Potential Market & Test Volume by Cancer Types (2015 – 2020)

8.    Liquid Biopsy Market – Recent Development

9.    Liquid Biopsy Market – Major Deals Analysis

10.    Liquid Biopsy Market – Driving Factors

11.    Liquid Biopsy Market – Challenges

Click here to view the report details: http://www.renub.com/united-states-liquid-biopsy-potential-testing-market-and-volume-analysis-to-2020-515-p.php

 Contact Us

 Rajat Gupta

Sr. Manager

Sales & Marketing Div

Renub Research

Email: [email protected]

Phone:  Phone:  +1-678-302-0700 (USA), +91-120-421-9822, +91-120-424-9780 (India)

Source: http://www.renub.com/united-states-liquid-biopsy-potential-testi